The KJPA elected CEO Hae-do Jung as the president

Published: 2015-03-27 13:30:59

Updated: 2015-03-27 13:30:59

The Korea Japanese Pharmaceutical Association, entering into Korea, appointed CEO Hae-do Jung of Astellas Pharma Korea as its president.

According to the Astellas Pharma Korea, CEO Hae-do Jung was elected to lead the KJPA as the president for 2 years at the regular meeting on the 24^th.

The KJPA is a group of presidents of Japanese pharmaceutical companies and healthcare companies branched in ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.